FIELD: medicine.
SUBSTANCE: method for prevention involves the three-week stress-protection therapy, diet therapy, omega 3 fatty acid deficiency therapy, vitamin therapy, probiotic therapy, probiotic-like therapy, antioxidant therapy, and local immunocorrective therapy.
EFFECT: method enables more effective prevention ensured by reducing the microecological imbalance, endotoxinemia, carrier state of viral and bacterial pathogens on the upper airway mucosa and recovery of local immune reactivity, colonisation resistance and nasal mucociliary clearance.
11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING (THERAPY OF) COMPENSATED NON-SPECIFIC CHRONIC TONSILLITIS | 2012 |
|
RU2510749C1 |
| HORMONE D (VITAMIN D) AND ITS DERIVATIVES FOR THE TREATMENT AND PREVENTION OF CANCER | 2019 |
|
RU2794340C1 |
| HOMEOPATHIC PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE AND EXAMINATION OF CHRONIC INFLAMMATORY DISEASES OF THE UPPER AND LOWER RESPIRATORY TRACT ON THE BASIS OF NATURAL COMPONENTS OF PLANT, ANIMAL AND MINERAL ORIGIN AND ITS USE | 2022 |
|
RU2798661C1 |
| METHOD FOR PREDICTING THREAT OF EARLY TERMINATION OF PREGNANCY DURING EXACERBATION OF CYTOMEGALOVIRUS INFECTION BY DETERMINING Α-TOCOPHEROL AND W-3 POLYUNSATURATED FATTY ACIDS IN BLOOD SERUM | 2021 |
|
RU2751650C1 |
| THERAPEUTIC NUTRIENT COMPOSITION | 2014 |
|
RU2571815C1 |
| METHOD FOR INCREASING RESISTANCE OF THE HUMAN BODY TO THE COMBINED CYTOTOXIC EFFECT OF SELENIUM AND COPPER OXIDE NANOPARTICLES | 2022 |
|
RU2786819C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING EXHIBITING PROPERTY OF ENDOTHELIAL DYSFUNCTION REDUCTION ACCOMPANYING CARDIOVASCULAR DISEASES | 2011 |
|
RU2505290C2 |
| USE OF PREPARATION CONTAINING AMMONIUM GLYCYRRHIZINATE AS ACTIVE INGREDIENT IN ANTI-INFLAMMATORY THERAPY OF POLYPOUS RHINOSINUSITIS | 2023 |
|
RU2817652C1 |
| METHOD OF TREATING ULCERATIVE COLITIS | 2023 |
|
RU2814765C1 |
| METHOD FOR DIAGNOSIS OF LIGHT DESYNCHRONOSIS | 2020 |
|
RU2748686C1 |
